Qaigen is a biotechnology company headquartered in Venlo, Netherlands and founded by Metin Colpan in 1984. Qaigen is a publicly traded company on the New York Stock and Frankfurt Prime Standard exchanges. Qiagen has around 4,700 employees in over 35 locations in 25 countries around the world.
Qaigen supplies technologies that help private and public scientists perform molecular diagnostics and applied testing in their experiments and//or tests. Their products are used for research and testing in several industries which include: healthcare, veterinary practices, forensics, food safety, pharmaceutical, bioinformatics, biotechnology, and life science.
History of Qiagen N.V. - FundingUniverse
International Directory of Company Histories, Vol. 39. St. James Press, 2001.
QIAGEN and NeuMoDx Announce Strategic Partnership to Offer Next-Generation Systems for Fully Integrated Molecular Diagnostic Testing
Qiagen launches molecular analysis panel for GI disorders in Europe
Medical Device Network